Results 101 to 110 of about 7,925 (224)
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1 [PDF]
Objectives Membrane-targeted application of complement inhibitors may ameliorate ischemia/reperfusion (I/R) injury by directly targeting damaged cells. We investigated whether Mirococept, a membrane-targeted, myristoylated peptidyl construct derived from
Banz, Yara +9 more
core
Anaphylatoxin and Anaphylaxis: VII. Peptone Anaphylatoxin [PDF]
F. G. Novy, P. H. DeKruif, F. O. Novy
openaire +1 more source
Objectives/Goals: Germinal matrix hemorrhage (GMH) is a devastating disease of infancy that results in brain-related pathologies. Following rupture of vasculature in the brain, red blood cell (RBC) lysis, and hemoglobin breakdown results in heme/iron ...
Devin Hatchell +3 more
doaj +1 more source
Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine [PDF]
Immunologic reactions to protamine sulfate during cardiac surgery are very rare. The frequency and outcome of such adverse reactions is unclear. We report a case of lethal anaphylactic reaction to protamine that occurred in a non-diabetic patient ...
Chevalley, C. +3 more
core
Complement depletion during haemofiltration with polyacrilonitrile membranes [PDF]
Background Polyacrylonitrile (PAN, AN69®) dialysis membranes have been shown to improve the outcome of critically ill patients. Factor D is an essential enzyme of the alternative pathway of complement and is increased during renal failure.
Chevrolet, Jean-Claude +5 more
core
The complement cascade in lung injury and disease
Background The complement system is an important arm of immune defense bringing innate and adaptive immunity. Although originally regarded as a major complementary defense mechanism against pathogens, continuously emerging evidence has uncovered a ...
M. G. Detsika +4 more
doaj +1 more source
The Role of Complement Anaphylatoxins (C3a and C5a) in Non-small Cell Lung Cancer: A Systematic Review. [PDF]
Skarentzos K +4 more
europepmc +1 more source

